GlassScriptPhysician profile
Vibhay Bhatnagar
NPI 1679507347
$326.14
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2021: $109.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $109.09 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.35 | 2019 | |
| Sanofi-Aventis U.S. LLC | $45.20 | 2019 | |
| Janssen Pharmaceuticals, INC | $32.87 | 2019 | |
| Boston Scientific Corporation | $18.67 | 2019 | |
| Amgen INC. | $14.38 | 2019 | |
| Genentech USA, INC. | $14.06 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.00 | 2019 | |
| Astellas Pharma US INC | $12.52 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vibhay Bhatnagar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.